Skip to main navigation Skip to search Skip to main content

Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells

  • Scott Maxwell
  • , Jun Okabe
  • , Harikrishnan Kaipananickal
  • , Hanah Rodriguez
  • , Ishant Khurana
  • , Keith Al-Hasani
  • , Bryna S.M. Chow
  • , Eleni Pitsillou
  • , Tom C. Karagiannis
  • , Karin Jandeleit-Dahm
  • , Ronald C.W. Ma
  • , Yu Huang
  • , Juliana C.N. Chan
  • , Mark E. Cooper
  • , Assam El-Osta*
  • *Corresponding author for this work

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

68 Downloads (CityUHK Scholars)

Abstract

Background Hyperglycemia influences the development of glomerular endothelial cell damage, and nowhere is this more evident than in the progression of diabetic kidney disease (DKD). While the Set7 lysine methyltransferase is a known hyperglycemic sensor, its role in endothelial cell function in the context of DKD remains poorly understood.
Methods Single-cell transcriptomics was used to investigate Set7 regulation in a mouse model of DKD, followed by validation of findings using pharmacological and short hairpin RNA inhibition inhibition of Set7.
Results Set7 knockout (Set7KO) improved glomerular structure and albuminuria in a mouse model of diabetes. Analysis of single-cell RNA-sequencing data showed dynamic transcriptional changes in diabetic renal cells. Set7KO controls phenotype switching of glomerular endothelial cell populations by transcriptional regulation of the insulin growth factor binding protein 5 (IGFBP5). Chromatin immunoprecipitation assays confirmed that the expression of the IGFBP5 gene was associated with mono- and dimethylation of histone H3 lysine 4 (H3K4me1/2). This generalizability was investigated in human kidney and circulating hyperglycemic cells exposed to TGFβ1. We showed that the highly selective Set7 inhibitor (R)-PFI-2 hydrochloride attenuated indices associated with renal cell damage and mesenchymal transition, specifically (1) reactive oxygen species production, (2) IGFBP5 gene regulation, and (3) expression of mesenchymal markers. Furthermore, renal benefit observed in Set7KO diabetic mice closely corresponded in human glomerular endothelial cells with (R)-PFI-2 hydrochloride inhibition or Set7 short hairpin RNA silencing.
Conclusions Set7 regulates the phenotypic endothelial-mesenchymal transition switch and suggests that targeting the lysine methyltransferase could protect glomerular cell injury in DKD.
© 2024 Wolters Kluwer Health. All rights reserved.
Original languageEnglish
Pages (from-to)733-748
JournalJournal of the American Society of Nephrology
Volume35
Issue number6
Online published17 Apr 2024
DOIs
Publication statusPublished - Jun 2024

Funding

A. El-Osta: National Health and Medical Research Council (1154650, 0526681, and 2014763). National Health and Medical Research Council (1142262, 1078609, and 1027341) and National Science Foundation of China (81561128017). R.C.W. Ma: Research Grants Council Impact Fund (R4012-18). Y. Huang: RGC-Senior Research Fellow Scheme (SRFS2021-4S04).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • diabetes
  • diabetes mellitus
  • diabetic kidney disease
  • diabetic nephropathy
  • endothelium
  • gene expression
  • gene transcription

Publisher's Copyright Statement

  • This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/

RGC Funding Information

  • RGC-funded

Fingerprint

Dive into the research topics of 'Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells'. Together they form a unique fingerprint.

Cite this